Page results
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery for patients (or their family or carers) who have been referred to our service or are under the care of the team at this hospital.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
Advice on preventing the spread of flu and other respiratory viruses, to keep UCLH patients safe.
-
This page tells you about the procedure known as varicocele (pronounced VARI-CO-SEAL) embolisation.
-
This page explains what a gastroscopy is and what it involves.
-
This page provides information for patients who are due to be admitted to hospital for bowel surgery.
-
This page provides information about food and drink which may affect your ileostomy output.
File results
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0392 - Treatment/ medication for biologic medicines in gastroenterology
-
FOI/2023/0426 - Maternity services staffing levels
-
FOI/2023/0429 - Breast cancer treatment/ systemic anti-cancer therapies
-
FOI/2023/0342 - Self-administration of medication policies